Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Recommendation of "Hold" from Analysts

Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Recommendation of "Hold" from Analysts

Shares of Moderna, Inc. (NASDAQ:MRNA - Get Free Report) have been given a consensus recommendation of "Hold" by the twenty-four research firms that are covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a sell recommendation, thirteen have issued a

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) have received a consensus recommendation of “Hold” from the sixteen analysts that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and four have issued a buy recommendation on the […]